Search results
Pfizer sued by Kansas for allegedly hiding COVID vaccine risks, making false claims
NY Post via Yahoo News· 5 days agoThe lawsuit claims that, beginning shortly after the vaccine's rollout in early 2021, Pfizer...
Kansas Attorney General Kris Kobach sues Pfizer over marketing of COVID-19 vaccine
Wichita Eagle via Yahoo News· 5 days ago“In such an environment, it is imperative Kansans making that decision receive the truth,” he said. ...
Kobach sues Pfizer over COVID vaccine claims
KSNW Wichita via Yahoo News· 5 days agoKansas Attorney General Kris Kobach has filed a lawsuit against Pfizer. He says the company made misleading and deceptive claims about its COVID-19 ...
Kansas sues Pfizer over COVID vaccine for what Kris Kobach calls 'misleading marketing'
Gannett via AOL· 5 days agoKobach cited a study on rats injected with full doses of the COVID vaccine and a collection of...
Kansas sues Pfizer over COVID vaccine development and marketing
BenefitsPRO· 2 days agoPfizer failed to provide adequate information about the vaccine development process and potential ...
Feeling Sick After Your COVID Vaccine? According to Scientists, It’s Actually a Good Sign
SciTechDaily· 3 days agoA UCSF study suggests that side effects like headaches and chills from COVID-19 vaccines indicate a...
Pfizer stock price analysis: how PFE became a fallen angel | Invezz
Invezz· 4 days agoPfizer (NYSE: PFE) stock price has crashed hard in the past few years as demand for Covid-19 ...
Column: This GOP-leaning political polling firm has turned into a purveyor of anti-vaccine...
LA Times via Yahoo News· 3 days agoRasmussen reported that 19% replied in the affirmative; the poll had a margin of error of 3%. Such...
Results are looking promising for a combined COVID and flu vaccine—here's how it could benefit...
Medical Xpress· 7 days agoCombination vaccines have been successfully used for several decades in Australia and around the...
Gateway - Quartz
Quartz· 4 days agoPharma giant AstraZeneca aims to increase its revenue by a whopping 75% in 2030, up from the $45.8 billion it generated in 2023 — just as it pulls its COVID-19 vaccines off ...